NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine

ROCKVILLE, Md. — Novavax, Inc. today announced that it has begun enrollment in a Phase II clinical trial of its quadrivalent seasonal influenza virus-like particle (VLP) vaccine candidate. This randomized, …

Via finance.yahoo.com

This entry was posted on 27 March, 2012 at 19:49 and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Cancel

Connecting to %s

ViroBlogy

NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine

Rate this:

Share this:

Like this:

Related

Leave a Reply Cancel reply